CompletedNot applicableNCT03007953

Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II

The focus of the study is to test a nurse-led telephone-based palliative care intervention on improving the delivery of care for patients with newly diagnosed lung cancer. The study is a three site randomized control trial to determine the efficacy of the intervention on improving patients' quality of life, symptom burden, and satisfaction of care. Additionally, the study will test an innovative care delivery model to improve patients' access to palliative care. The investigators will also determine the effect of the intervention on patient activation to discuss treatment preferences with their clinician and on clinician knowledge of patients' goals of care.

Checked against the public recordLast updated Jul 27, 2023 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations3
SponsorVA Office of Research and Development
01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Not applicable
Sponsor
VA Office of Research and Development
Interventions being studied
Behavioral: Palliative Care
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: Patients diagnosed at the Puget Sound Health Care System, Birmingham VA, or Portland VA with a primary diagnosis of lung cancer that requires more than surgical resection: * diagnosed within 8 weeks of recruitment * must have telephone access * ability to understand English * able to participate in informed consent process Exclusion Criteria: Patients not eligible to participate in the study include those who are inpatients prior to randomization, * those who are under the care of palliative care or hospice at the time of randomization * those who have severe mental health disorders * those who are unable to speak directly with the nurse over the telephone * or those that have the inability to provide informed consent

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Birmingham VA Medical Center, Birmingham, ALBirmingham, Alabama
  • VA Portland Health Care System, Portland, ORPortland, Oregon
  • VA Puget Sound Health Care System Seattle Division, Seattle, WASeattle, Washington

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 27, 2023. Always confirm current availability with the study team.

View original record ↗